-
The Association for Professionals in Infection Control and Epidemiology (APIC) is tracking a growing body of proposed state legislation related to infection prevention in long term care. A selection of state bills proposed this year include the following:
-
Though there was considerable pushback from infection preventionists when the idea of a federal infectious disease standard was proposed last year, recent comments from the chief of OSHA reveal that the controversial regulation is still on the agenda.
-
Uldrick et al performed a pilot study in which 14 HIV-infected patients with symptomatic MCD received high-dose AZT (600 mg PO Q6 hours) and VGC (900 mg PO Q12 hours).
-
In this issue: Calcium supplements and MI; birth control pills and VTE; ACE inhibitors and breast cancer risk; spending on pharmaceuticals; and FDA actions.
-
-
On Feb. 15, 2011, a 30-month-old U.S.-born child of Somali descent developed a skin rash 14 days after returning from a trip to Kenya and 1 day after visiting a child care center.
-
Basically, people now feel nothing is safe to eat. They don't know what choices to make.
-
The April 14 issue of the New England Journal of Medicine contains two articles on boceprevir, a new designer molecule that has demonstrated a dramatic improvement in outcomes for patients with genotype 1 hepatitis C.
-
ZOSTAVAX®, which had previously received FDA approval for prevention of herpes zoster (HZ) and post-herpetic neuralgia in individuals 60 years of age and older, had its approval extended to include people 50-59 years of age on March 24, 2011.
-
A retrospective study was conducted of 563 children who presented over the last decade to two pediatric immunodeficiency centers in the United Kingdom.
